The Gene Targeting and Transgenic Mouse (GTTM) Share Resource assists Cancer Center members who use animal models in constructing and managing genetically altered mouse strains. It is operated by Dr. Sang-Yong Kim, a microinjection expert, and is supervised by Dr. Jacek Skowronski (Associate Investigator). The GTTM Shared Resource is equipped with two microinjection stations and support equipment that allow for generation of transgenic mice by direct DNA injection into fertilized zygotes and construction of chimeric mice using Embryonic Stem (ES) cell technologies. Service provided by the GTTM Shared Resource will initially include generation of transgenic animal models by pro-nuclear injection, maintenance of ES cell line stocks capable of efficient germline contribution for use in gene targeting experiments, generation of chimeric mice with genetically altered ES cells, and mouse embryo cryopreservation services. Funds are requested for the equipment necessary to establish ES cell culture and embryo cryopreservation services. The GTTM Shared Resource was recently established to meet the rising demand for these services from the Cancer Center members that use animal models that use animal models in their research. We predict that the GTTM Shared Resource will become an important resource for cancer researchers at CSHL, further promoting scientific interactions between CSHL investigators, and at other research institutions around the world.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA045508-15S1
Application #
6501458
Study Section
Subcommittee G - Education (NCI)
Project Start
2001-08-01
Project End
2002-07-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
15
Fiscal Year
2001
Total Cost
$78,870
Indirect Cost
Name
Cold Spring Harbor Laboratory
Department
Type
DUNS #
065968786
City
Cold Spring Harbor
State
NY
Country
United States
Zip Code
11724
Aberle, M R; Burkhart, R A; Tiriac, H et al. (2018) Patient-derived organoid models help define personalized management of gastrointestinal cancer. Br J Surg 105:e48-e60
Bhagwat, Anand S; Lu, Bin; Vakoc, Christopher R (2018) Enhancer dysfunction in leukemia. Blood 131:1795-1804
Khan, Jalal A; Maki, Robert G; Ravi, Vinod (2018) Pathologic Angiogenesis of Malignant Vascular Sarcomas: Implications for Treatment. J Clin Oncol 36:194-201
Chen, Wei-Chia; Tareen, Ammar; Kinney, Justin B (2018) Density Estimation on Small Data Sets. Phys Rev Lett 121:160605
Cheng, Derek; Tuveson, David (2018) Kras in Organoids. Cold Spring Harb Perspect Med 8:
Albrengues, Jean; Shields, Mario A; Ng, David et al. (2018) Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice. Science 361:
Cook, Natalie; Basu, Bristi; Smith, Donna-Michelle et al. (2018) A phase I trial of the ?-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinoma. Br J Cancer 118:793-801
Melnikov, Sergey V; Rivera, Keith D; Ostapenko, Denis et al. (2018) Error-prone protein synthesis in parasites with the smallest eukaryotic genome. Proc Natl Acad Sci U S A 115:E6245-E6253
Krishnan, Navasona; Bonham, Christopher A; Rus, Ioana A et al. (2018) Harnessing insulin- and leptin-induced oxidation of PTP1B for therapeutic development. Nat Commun 9:283
Pommier, Arnaud; Anaparthy, Naishitha; Memos, Nicoletta et al. (2018) Unresolved endoplasmic reticulum stress engenders immune-resistant, latent pancreatic cancer metastases. Science 360:

Showing the most recent 10 out of 380 publications